Frequency and Predictive Factors of Hypoglycemia in Patients Treated With rhIGF-1: Data From the Eu-IGFD Registry
The Journal of Clinical Endocrinology & Metabolism · 21.12.2023 · 109 (1) · 46-56
DOI: 10.1210/clinem/dgad479 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 14.08.2023. Verfasst von Peter Bang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Health Sciences, Linköping University, 581 83 Linköping, Sweden. Hauptthemen laut MEDLINE: Laron Syndrome, Hypoglycemia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ipsen.
Abstract (Originalsprache)
Context
The European Increlex® Growth Forum Database (Eu-IGFD) is an ongoing surveillance registry (NCT00903110) established to collect long-term safety and effectiveness data on the use of recombinant human insulin-like growth factor-1 (rhIGF-1, mecasermin, Increlex) for the treatment of children/adolescents with severe primary insulin-like growth factor-1 deficiency (SPIGFD).
Objective
This analysis of Eu-IGFD data aimed to identify the frequency and predictive factors for hypoglycemia adverse events (AEs) in children treated with rhIGF-1.
Methods
Data were collected from December 2008 to May 2021. Logistic regression was performed to identify predictive risk factors for treatment-induced hypoglycemia AEs. Odds ratios (ORs) are presented with 95% CIs for each factor.
Results
In total, 306 patients were enrolled in the registry; 84.6% were diagnosed with SPIGFD. Patients who experienced ≥ 1 hypoglycemia AE (n = 80) compared with those with no hypoglycemia AEs (n = 224) had a lower mean age at treatment start (8.7 years vs 9.8 years), a more frequent diagnosis of Laron syndrome (27.5% vs 10.3%), and a history of hypoglycemia (18.8% vs 4.5%). Prior history of hypoglycemia (OR 0.25; 95% CI: [0.11; 0.61]; P = .002) and Laron syndrome diagnosis (OR 0.36; 95% CI: [0.18; 0.72]; P = .004) predicted future hypoglycemia AEs. Total hypoglycemia AEs per patient per treatment year was 0.11 and total serious hypoglycemia AEs per patient per treatment year was 0.01.
Conclusion
Hypoglycemia occurs more frequently in patients with prior history of hypoglycemia and/or Laron syndrome compared with patients without these risk factors, and these patients should be carefully monitored for this AE throughout treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Health Sciences, Linköping University, 581 83 Linköping, Sweden.
- Department of Pediatric Endocrinology, Gynaecology, and Diabetology, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Necker-Enfants Malades, 75015 Paris, France.
- IMAGINE Institute, INSERM U1016, France University of Paris Cité, 75015 Paris, France.
- Department of Pediatrics, Endocrinology, Diabetology with Cardiology Division, Medical University of Białystok, 15-274 Białystok, Poland.
- Department of Pediatrics, IRCCS Istituto Giannina Gaslini, 16100 Genova, Italy.
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health University of Genova, 16132 Genova, Italy.
ORCID-Profile: Artur Bossowski, Mohamad Maghnie, Jesús Argente, Marta Ramon-Krauel, Joachim Woelfle
Förderung
- Ipsen
Zitieren
APA
Bang, P., Polak, M., Bossowski, A., Maghnie, M., Argente, J., Ramon-Krauel, M., Sert, C., Perrot, V., Mazain, S., & Woelfle, J. (2023). Frequency and Predictive Factors of Hypoglycemia in Patients Treated With rhIGF-1: Data From the Eu-IGFD Registry. The Journal of Clinical Endocrinology & Metabolism, 109(1), 46-56. https://doi.org/10.1210/clinem/dgad479
Vancouver
Bang P, Polak M, Bossowski A, Maghnie M, Argente J, Ramon-Krauel M, et al. Frequency and Predictive Factors of Hypoglycemia in Patients Treated With rhIGF-1: Data From the Eu-IGFD Registry. The Journal of Clinical Endocrinology & Metabolism. 2023;109(1):46-56. doi:10.1210/clinem/dgad479
BibTeX
@article{Bang2023,
author = {Bang, Peter and Polak, Michel and Bossowski, Artur and Maghnie, Mohamad and Argente, Jesús and Ramon-Krauel, Marta and Sert, Caroline and Perrot, Valerie and Mazain, Sarah and Woelfle, Joachim},
title = {Frequency and Predictive Factors of Hypoglycemia in Patients Treated With rhIGF-1: Data From the Eu-IGFD Registry},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {109},
number = {1},
pages = {46--56},
doi = {10.1210/clinem/dgad479}
}
EUVIMED